FDA approves new gonorrhea antibiotics from GSK and Innoviva on December 12, 2025 Antibiotic Resistance, Microbial Approved Blujepa gepotidacin Gonorrhea Innoviva Nuzolvence SmithKline Beecham United States Food and Drug Administration zoliflodacin +
FDA Approves GSK's Gepotidacin (Blujepa) for Uncomplicated Urogenital Gonorrhea on December 12, 2025 Antibiotics Approved Blujepa gepotidacin Gonorrhea SmithKline Beecham United States Food and Drug Administration +
FDA Approves Blujepa: First New Oral Antibiotic for Uncomplicated UTIs in Nearly 30 Years on March 26, 2025 Approved Blujepa first-in-class antibiotic gepotidacin SmithKline Beecham United States Food and Drug Administration Urinary tract infection uUTIs +